This article shows that all hospitalized patients may benefit from at least an intermediate anti-coagulation treatment.
Link to the article.
Link to the pdf version.
doi: Link
To quote this article in bibliography:
Poulakou, Garyphallia, Evangelos Dimakakos, Anastasios Kollias, et al. “Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study." In Vivo 35, no. 1 (2021): 653-661. https://doi.org/10.21873/invivo.12305